Active • Host: E. coli • AA: 29-209 • Tag: N-terminal His • MW: 20.2 kDa
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

FGF21 (human, recombinant)

Item No. 32027

Technical Information
Synonyms
  • FGF21
  • Fibroblast Growth Factor 21
Purity
≥95% estimated by SDS-PAGE
Source
Recombinant human N-terminal His-tagged mature FGF21 expressed in E. coli
Amino Acids
29-209
MW
20.2 kDa
50 mM Tris, 200 mM sodium chloride, pH 8.8, 5% Trehalose, 5% Mannitol, and 0.01% Tween-80
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    Fibroblast growth factor 21 (FGF21) is a hepatokine and member of the endocrine subfamily of FGFs with roles in energy homeostasis, insulin sensitivity, and metabolic regulation.1,2 Mature FGF21 is a 181-amino acid peptide composed of an N-terminal FGFR binding site, a conserved 120-amino acid core, and a C-terminal sequence that facilitates binding to the klotho beta (KLB) co-receptors.2 It is derived from a 209-amino acid protein that contains an additional 28-amino acid hydrophobic signaling peptide that drives constitutive secretion. FGF21 is primarily expressed in the liver but is also synthesized in white adipose tissue, skeletal muscle, pancreas, the digestive tract, and cardiac muscle.1,2 It forms a complex with KLB and FGFR1c, -2c, -3c, or -4 to induce FGFR dimerization and signaling.1 Liver levels of FGF21 are increased in a mouse model of non-alcoholic fatty liver disease (NAFLD) induced by a methionine- and choline-deficient diet, and knockdown of Fgf21 increases hepatic triglyceride accumulation and fibrosis in mice. Exogenous administration of FGF21 induces weight loss, improves glucose tolerance, and increases the browning of white adipose tissue in a mouse model of diet-induced obesity. Administration of FGF21 also reduces ad libitum alcohol consumption in mice, and plasma levels of FGF21 are increased in humans following acute alcohol ingestion.3 Cayman's FGF21 (human, recombinant) protein can be used for Western blot and cell-based assay applications. This protein is mature FGF21 that consists of 188 amino acids and has a calculated molecular weight of 20.2 kDa. By SDS-PAGE, under reducing conditions, the protein migrates at approximately 23 kDa.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Fisher, F.M., and Maratos-Flier, E. Understanding the physiology of FGF21. Annu. Rev. Physiol. 78, 223-241 (2016).

    2. Kilkenny, D.M., and Rocheleau, J.V. The FGF21 receptor signaling complex: Klothoβ, FGFR1c, and other regulatory interactions. Vitam. Horm. 101, 17-58 (2016).

    3. Søberg, S., Andersen, E.S., Dalsgaard, N.B., et alFGF21, a liver hormone that inhibits alcohol intake in mice, increases in human circulation after acute alcohol ingestion and sustained binge drinking at Oktoberfest. Mol. Metab. 11, 96-103 (2018).